Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine

Vaccine

Volumn 17, Issue 4, 1999, Pages 330-339

  McDermott, A B ^a   Cohen, S B A ^a,b   Zuckerman, J N ^b   Madrigal, J A ^a,b  

^a ANTHONY NOLAN RESEARCH INSTITUTE   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

HBsAg; Hepatitis B vaccination; Pre S

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; HLA ANTIGEN; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG RESPONSE; GENOTYPE; HEPATITIS B; HLA TYPING; HUMAN; HUMAN CELL; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVACCINATION;

EID: 0344734069     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00203-5     Document Type: Article

References (34)

1. Chang M.H., Chen C.J., Lai M.S.et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med. 336:1997;1855-1907.
2. Hadler S., Francis D., Maynard J.et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med. 315(4):1986;209-214.
3. Wood R.C., MacDonald K.L., White K.E., Hedberg C.W., Hanson M., Osterholm M.T. Risk factors for the lack of antibody following hepatitis B vaccination of Minnesota health care workers. JAMA. 270(24):1993;2935-2939.
4. Margolis H., Presson A. Host factors related to poor immunogenicity of hepatitis B vaccine in adults (editorial). JAMA. 270:1993;2971-2972.
5. Craven D.E., Awdeh Z.L., Kunches L.M.et al. Nonresponsiveness to hepatitis B vaccine in health care workers. Ann Int Med. 105:1986;356-360.
6. McDermott A.B., Zuckerman J.N., Sabin C.A., Marsh S.G.E., Madrigal J.A. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens. 50:1997;8-14.
7. Zuckerman J.N., Sabin C., Craig F.M., Williams A., Zuckerman A.J. Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose response study. BMJ. 314:1997;329-333.
8. Jilg W., Schmidt M., Deinhardt F. Immune response to hepatitis B revaccination. J Med Virol. 24:1988;377-384.
9. Jilg W., Schmidt M., Deinhardt F. Four-year experience with a recombinant hepatitis B vaccine. Infection. 17(2):1989;70-76.
10. Westmoreland D., Player V., Heap D.C., Hammond A. Immunisation against hepatitis B: what can we expect? Epidemiol Infect. 104:1990;499-509.
11. Courouce AM, Laplanche A, Benhamou E, Jungers P. Long term efficiency of hepatitis B vaccine in healthy adults. In: Zuckerman AJ, editor. Viral hepatitis and liver disease. New York: Alan R Liss, 1988. p. 1002-5.
12. Struve J., Aronsson B., Forsgren M., Weiland O. Response to a booster dose 18 months after a low anti-HBs response (10-99 IU/l) to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine. Infection. 23(1):1995;42-45.
13. Nagafuchi S., Kashiwagi S., Okada K.et al. Reversal of nonresponders and postexposure prophylaxis by intradermal hepatitis B vaccination in Japanese medical personnel. JAMA. 265(20):1991;2679-2683.
14. Clemens R., Sanger R., Kruppenbacher J.et al. Booster immunisation of low and nonresponders after a standard three dose hepatitis B vaccine schedule-results of a post marketing surveillance. Vaccine. 15(4):1997;349-352.
15. 1 antigens and antibodies early in the course of acute Hepatitis B virus infection. J Virol. 58(2):1986;522-525.
16. Milich D., McLachlan A., Chisari F., Kent B., Thornton G. Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1) specific T-cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg. J Immunol. 137(1):1986;315-322.
17. Neurath A.R., Kent S.B.H., Stick N. Location and chemical synthesis of a pre-S gene coded immunodominant epitope of hepatitis B virus. Science. 224:1984;392-395.
18. Neurath A.R., Kent S.B.H., Strick N., Parker K. Identification and chemical synthesis of host-cell receptor binding on hepatitis B virus. Cell. 46:1986;429-436.
19. Samanta H., Toun B.W. Expression of hepatitis B surface antigen containing the pre-S region in mammalian cell culture system. Vaccine. 7:1989;69-76.
20. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res. 16:1988;1215-1218.
21. Jordan F., McWhinney A.J., Turner S.et al. Comparison of HLA-DRB1 typing by DNA-RFLP, PCR-SSO and PCR-SSP methods and their application in providing matched unrelated donors for bone marrow transplantation. Tissue Antigens. 45:1995;103-110.
22. Alper C. The human immune response hepatitis B surface antigen. Exp Clin Immunogenet. 12:1995;171-181.
23. Steinman R.M. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol. 9:1991;1849-1860.
24. Goodnow C.C. Chance encounters and organised rendezvous. Immunol Rev. 156:1997;5-10.
25. Milich D.R., Thornton G.B., Neurath A.R., Kent S.B., Tiollais M.L., Chisari F.V. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science. 228:1985;1195-1198.
26. Cupps T.R., Gerin J.L., Purcell R.H., Goldsmith P.K., Fauci A.S. In vitro antigen induced antibody responses to hepatitis B surface antigen in man. J Clin Invest. 74:1984;1204-1213.
27. Egea E., Iglesias A., Salazar M.et al. The cellular basis for lack of response to hepatitis B vaccine in humans. J Exp Med. 173:1991;531-538.
28. Celis E., Kung P., Chang T. Hepatitis B virus reactive human T lymphocyte clones, antigen specificity and helper function for antibody synthesis. J Immunol. 132(3):1984;1511-1516.
29. Leroux-Roels G., Van Hecke E., Michielsen W., Voet P., Hauser P., Petre J. Correlation between in vivo humoral and in vitro cellular immune responses following immunisation with hepatitis B surface antigen (HBsAg) vaccines. Vaccine. 12(9):1994;812-818.
30. Nossal G.J. Immunological tolerance then and now: was the Medawar school right? Immunol Suppl. 2:1989;2-5.
31. Janeway Ca. Jr. The T-cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T-cell activation. Annu Rev Immunol. 10:1992;645-674.
32. Rocha B., Von Boehmer H. Peripheral selection of the T-cell repertoire. Science. 254:1991;1225-1228.
33. Kyburz D., Aichele P., Speiser D.E., Hentgartner H., Zinkernagel R.M., Pircher H. T-cell immunity after a viral infection versus T-cell tolerance induced by soluble peptides. Eur J Immunol. 23:1993;1956-1962.
34. Schwartz R.H. Models of T-cell anergy: is there a common molecular mechanism? J Exp Med. 184:1996;1-8.